Selection of Leptin Surrogates by a General Phenotypic Screening Method for Receptor Agonists

• Published in: Biomolecules (Basel, Switzerland) Vol. 14; no. 4; p. 457
• Main Authors: Wang, Tao, Chen, Xixi, Yang, Guang, Shi, Xiaojie
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.04.2024
• Subjects: Agonists; Agonists (Biochemistry); Antibodies; biological receptor activation-dependent cell survival (BRADS); Cell activation; Cell culture; Cell survival; Cell Survival - drug effects; Cloning; cytokine surrogate; Cytokines; Diabetes; Energy consumption; Flow cytometry; Growth factors; HEK293 Cells; high-throughput screening; High-throughput screening (Biochemical assaying); High-Throughput Screening Assays - methods; Humans; Immune system; Leptin; Leptin - metabolism; Ligands; Methods; Phenotype; phenotypic screening; Phosphatase; Physiological aspects; receptor agonist; Receptor mechanisms; Receptors, Leptin - agonists; Receptors, Leptin - metabolism; China; United States > US; phenotypic screening; receptor agonist; biological receptor activation-dependent cell survival (BRADS); high-throughput screening; cytokine surrogate
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom14040457

There is a high demand for agonist biomolecules such as cytokine surrogates in both biological and medicinal research fields. These are typically sourced through natural ligand engineering or affinity-based screening, followed by individual functional validation. However, efficient screening methods for identifying rare hits within immense libraries are very limited. In this research article, we introduce a phenotypic screening method utilizing biological receptor activation-dependent cell survival (BRADS). This method offers a high-throughput, low-background, and cost-effective approach that can be implemented in virtually any biochemical laboratory setting. As a proof-of-concept, we successfully identified a surrogate for human leptin following a two-week cell culture process, without the need for specialized high-throughput equipment or reagents. This surrogate effectively emulates the activity of native human leptin in cell validation assays. Our findings not only underscore the effectiveness of BRADS but also suggest its potential applicability to a broad range of biological receptors, including Notch and GPCRs.